BioSpace News Archive

Business

Case Western Reserve University and Akouos sign exclusive licensing agreement to advance development of gene therapy technology as a potential treatment for a type of Usher syndrome

Case Western Reserve University and Boston-based Akouos have entered into an exclusive licensing agreement to develop a patented gene therapy with the potential to treat hearing loss associated with a type of Usher syndrome, the most common deaf-blind disorder.

September 8, 2019
·
3 min read
Genetown

Jett Foundation Hosts Celebration of World Duchenne Awareness Day 2019 in Waltham

Jett Foundation, a non-profit organization dedicated to raising awareness and funds for Duchenne muscular dystrophy, will celebrate World Duchenne Awareness Day (WDAD) on Saturday, September 7.

September 8, 2019
·
3 min read
Job Trends

The Paradox of Different House Flies with Few Genetic Differences

UH Evolutionary Biologist Publishes Findings on Sex Determinates of House Flies

September 8, 2019
·
2 min read
Job Trends

SEKISUI XenoTech Announces Expanded Consulting Opportunities Available to Clients

KS- SEKISUI XenoTech now provides the opportunity for clients to work with top-tier consultants to analyze critical components of absorption, distribution, metabolism, and excretion of their drug candidate to optimize the data package for regulatory submission.

September 8, 2019
·
3 min read
Deals

Cardea Bio and Nanosens Innovations look to combine companies

The Board of Directors of Cardea Bio and the Board of Directors of Nanosens Innovations have each authorized the respective companies to proceed with a proposed business combination.

September 8, 2019
·
3 min read
Drug Development

Amgen Announces New Clinical Data Evaluating Novel Investigational KRAS(G12C) Inhibitor In Larger Patient Group At WCLC 2019

Amgen announced new data from the ongoing Phase 1 study evaluating AMG 510 in patients with previously treated KRAS G12C-mutated solid tumors.

September 8, 2019
·
11 min read
Genetown

FMCNA and ANNA Celebrate Nephrology Nurses Week, Recognizing the Role Nephrology Nurses Play in Patients’ Lives

The collaborative partnership is part of a multi-year effort to advance the nephrology nursing profession

September 8, 2019
·
3 min read
pt Health named to the 2019 List of Best Workplaces™ in Healthcare

Mentorship, feedback and team work among pillars of Company’s vibrant workplace

September 8, 2019
·
3 min read
Biotech Bay

Aridis Pharmaceuticals to Present at the H.C. Wainwright 21st Annual Global Investment Conference on September 10, 2019

Aridis Pharmaceuticals, Inc. announced that Vu Truong, Ph.D., Chief Executive Officer, will present at the H.C. Wainwright 21st Annual Global Investment Conference.

September 8, 2019
·
5 min read
Drug Development

Ipsen and Servier announce initial Phase II/III clinical data evaluating investigational liposomal irinotecan (ONIVYDE®) as a second-line treatment for small cell lung cancer (SCLC) at the IASLC 2019 World Conference on Lung Cancer

Ipsen and Servier announced initial safety and efficacy data from Part 1 of the Phase II/III RESILIENT study of investigational liposomal irinotecan in patients with small cell lung cancer who progressed following a first-line platinum-based regimen.

September 8, 2019
·
16 min read